Alaunos Therapeutics reported $2.8M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bioline Rx USD 19.53M 537K Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Celltrion KRW 16.7T 182.36B Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Cspc Pharmaceutical CNY 33.25B 984.93M Jun/2025
Curis USD -13.99M 7.38M Jun/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Intrexon USD 43.17M 75.33M Jun/2024
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
J&J USD 78.47B 0 Sep/2025
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 55.1M 229K Jun/2025
Merck USD 51.85B 2.79B Sep/2025
Neuren Pharmaceuticals AUD 323.27M 40.63M Jun/2025
Novartis USD 44.75B 2.7B Sep/2025
Organigram Holdings CAD 349.13M 36.37M Sep/2025
Ovoca Bio EUR 8.67M 4.76M Jun/2022
Pfizer USD 92.8B 4.11B Sep/2025
Pharma Mar EUR 197.51M 4.02M Sep/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sartorius EUR 2.67B 9.9M Sep/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
Tilray USD 1.51B 1.22B Mar/2025
Verastem USD -32.43M 3.54M Mar/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025